Citation: | WANG Xingbin, ZHAO Changming, HUANG Qiuli, WANG Ling, ZHANG Yaxin, YANG Dejie, WANG Zhaofen. Mendelian randomization study on the causal relationship between interleukins and pulmonary tuberculosis[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2024, 28(7): 827-832. doi: 10.16462/j.cnki.zhjbkz.2024.07.013 |
[1] |
Petersen E, Al-abri S, Chakaya J, et al. World TB Day 2022: revamping and reshaping global TB control programs by advancing lessons learnt from the COVID-19 pandemic[J]. Int J Infect Dis, 2022, 124: S1-S3. DOI: 10.1016/j.ijid.2022.02.057.
|
[2] |
Kumar NP, Moideen K, Banurekha VV, et al. Plasma proinflammatory cytokines are markers of disease severity and bacterial burden in pulmonary tuberculosis[J]. Open Forum Infect Dis, 2019, 6(7): ofz257. DOI: 10.1093/ofid/ofz257.
|
[3] |
Moideen K, Kumar NP, Bethunaickan R, et al. Heightened systemic levels of anti-inflammatory cytokines in pulmonary tuberculosis and alterations following anti-tuberculosis treatment[J]. Cytokine, 2020, 127: 154929. DOI: 10.1016/j.cyto.2019.154929.
|
[4] |
和思敏, 张雨, 彭刘庆, 等. 倾向性评分与孟德尔随机化国内研究现状[J]. 中华疾病控制杂志, 2022, 26(3): 325-330. DOI: 10.16462/j.cnki.zhjbkz.2022.03.014.
He SM, Zhang Y, Peng LQ, et al. Research progress of propensity score and Mendelian randomization in China[J]. Chin J Dis Control Prev, 2022, 26(3): 325-330. DOI: 10.16462/j.cnki.zhjbkz.2022.03.014.
|
[5] |
Folkersen L, Gustafsson S, Wang Q, et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30 931 individuals[J]. Nat Metab, 2020, 2(10): 1135-1148. DOI: 10.1038/s42255-020-00287-2.
|
[6] |
Ahola-olli AV, Würtz P, Havulinna AS, et al. Genome-wide association study identifies 27 loci influencing concentrations of circulating cytokines and growth factors[J]. Am J Hum Genet, 2017, 100(1): 40-50. DOI: 10.1016/j.ajhg.2016.11.007.
|
[7] |
李文超, 李洪凯, 刘新辉, 等. 基于孟德尔随机化探索臀围与2型糖尿病的因果关系[J]. 中华疾病控制杂志, 2020, 24(1): 9-13, 19. DOI: 10.16462/j.cnki.zhjbkz.2020.01.003.
Li WC, Li HK, Liu XH, et al. Exploring the causal relationship between hip circumference and type 2 diabetes based on mende lian randomization[J]. Chin J Dis Control Prev, 2020, 24(1): 9-13, 19. DOI: 10.16462/j.cnki.zhjbkz.2020.01.003.
|
[8] |
Feng R, Lu M, Xu J, et al. Pulmonary embolism and 529 human blood metabolites: genetic correlation and two-sample Mendelian randomization study[J]. BMC Genomic Data, 2022, 23(1): 69. DOI: 10.1186/s12863-022-01082-6.
|
[9] |
Burgess S, Butterworth A, Thompson S G. Mendelian randomization analysis with multiple genetic variants using summarized data[J]. Genet Epidemiol, 2013, 37(7): 658-665. DOI: 10.1002/gepi.21758.
|
[10] |
Bowden J, Davey SG, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression[J]. Int J Epidemiol, 2015, 44(2): 512-525. DOI: 10.1093/ije/dyv080.
|
[11] |
Bowden J, Davey SG, Haycock PC, et al. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator[J]. Genet Epidemiol, 2016, 40(4): 304-314. DOI: 10.1002/gepi.21965.
|
[12] |
Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method[J]. Eur J Epidemiol, 2017, 32(5): 377-389. DOI: 10.1007/s10654-017-0255-x.
|
[13] |
Cohen JF, Chalumeau M, Cohen R, et al. Cochran's Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracy[J]. J Clini Epidemiol, 2015, 68(3): 299-306. DOI: 10.1016/j.jclinepi.2014.09.005.
|
[14] |
Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases[J]. Nat Genet, 2018, 50(5): 693-698. DOI: 10.1038/s41588-018-0099-7.
|
[15] |
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing[J]. J R Stat Soci, 1995, 57(1): 289-300. DOI: 10.1111/j.2517-6161.1995.tb02031.x.
|
[16] |
Mannie MD, Abbott DJ, Blanchfield L. Cytokine-neuroantigen fusion proteins represent a novel therapeutic approach for EAE (48.10)[J]. J Immunol, 2009, 182(Sup 1): 48.10. DOI: 10.4049/jimmunol.182.Supp.48.10.
|
[17] |
Qin XJ. Interleukin-16 in tuberculous and malignant pleural effusions[J]. Eur Respir J, 2005, 25(4): 605-611. DOI: 10.1183/09031936.05.00090804.
|
[18] |
Su H, Weng S, Luo L, et al. Mycobacterium tuberculosis hijacks host macrophages-derived interleukin 16 to block phagolysosome maturation for enhancing intracellular growth: IL-16 enhances Mtb intracellular survival[J]. Emerg Microbes Infec, 2024: 2322663. DOI: 10.1080/22221751.2024.2322663.
|
[19] |
Pflanz S, Timans JC, Cheung J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells[J]. Immunity, 2002, 16(6): 779-790. DOI: 10.1016/S1074-7613(02)00324-2.
|
[20] |
Remoli ME, Gafa V, Giacomini E, et al. IFN-β modulates the response to TLR stimulation in human DC: involvement of IFN regulatory factor-1 (IRF-1) in IL-27 gene expression[J]. Eur J Immunol, 2007, 37(12): 3499-3508. DOI: 10.1002/eji.200737566.
|
[21] |
Pirhonen J, Sirén J, Julkunen I, et al. IFN-α regulates toll-like receptor-mediated IL-27 gene expression in human macrophages[J]. J Leukocyte Biol, 2007, 82(5): 1185-1192. DOI: 10.1189/jlb.0307157.
|
[22] |
Moideen K, Kumar NP, Bethunaickan R, et al. Heightened systemic levels of anti-inflammatory cytokines in pulmonary tuberculosis and alterations following anti-tuberculosis treatment[J]. Cytokine, 2020, 127: 154929. DOI: 10.1016/j.cyto.2019.154929.
|
[23] |
Skouras VS, Magkouta SF, Psallidas I, et al. Interleukin-27 improves the ability of adenosine deaminase to rule out tuberculous pleural effusion regardless of pleural tuberculosis prevalence[J]. Infect Dis, 2015, 47(7): 477-483. DOI: 10.3109/23744235.2015.1019919.
|
[24] |
Torrado E, Fountain JJ, Liao M, et al. Interleukin 27R regulates CD4+ T cell phenotype and impacts protective immunity during Mycobacterium tuberculosis infection[J]. J Exp Med, 2015, 212(9): 1449-1463. DOI: 10.1084/jem.20141520.
|
[25] |
Erdmann H, Behrends J, Ritter K, et al. The increased protection and pathology in Mycobacterium tuberculosis-infected IL-27R-alpha-deficient mice is supported by IL-17A and is associated with the IL-17A-induced expansion of multifunctional T cells[J]. Mucosal Immunol, 2018, 11(4): 1168-1180. DOI: 10.1038/s41385-018-0026-3.
|